BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 20015945)

  • 1. Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate.
    Mizutani M; Ito Y; Mizuno M; Nishimura H; Suzuki Y; Hattori R; Matsukawa Y; Imai M; Oliver N; Goldschmeding R; Aten J; Krediet RT; Yuzawa Y; Matsuo S
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F721-33. PubMed ID: 20015945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of CCN2/CTGF and related cytokines in cultured peritoneal cells under conditions simulating peritoneal dialysis.
    Leung JC; Chan LY; Tam KY; Tang SC; Lam MF; Cheng AS; Chu KM; Lai KN
    Nephrol Dial Transplant; 2009 Feb; 24(2):458-69. PubMed ID: 18805993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connective tissue growth factor and its regulation in the peritoneal cavity of peritoneal dialysis patients.
    Zarrinkalam KH; Stanley JM; Gray J; Oliver N; Faull RJ
    Kidney Int; 2003 Jul; 64(1):331-8. PubMed ID: 12787426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition effect of small interfering RNA of connective tissue growth factor on the expression of vascular endothelial growth factor and connective tissue growth factor in cultured human peritoneal mesothelial cells.
    Liu FY; Xiao L; Peng YM; Duan SB; Liu H; Liu YH; Ling GH; Yuan F; Chen JX; Fu X; Zhu JL
    Chin Med J (Engl); 2007 Feb; 120(3):231-6. PubMed ID: 17355828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β1 promotes lymphangiogenesis during peritoneal fibrosis.
    Kinashi H; Ito Y; Mizuno M; Suzuki Y; Terabayashi T; Nagura F; Hattori R; Matsukawa Y; Mizuno T; Noda Y; Nishimura H; Nishio R; Maruyama S; Imai E; Matsuo S; Takei Y
    J Am Soc Nephrol; 2013 Oct; 24(10):1627-42. PubMed ID: 23990681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis.
    Bellón T; Martínez V; Lucendo B; del Peso G; Castro MJ; Aroeira LS; Rodríguez-Sanz A; Ossorio M; Sánchez-Villanueva R; Selgas R; Bajo MA
    Nephrol Dial Transplant; 2011 Sep; 26(9):2995-3005. PubMed ID: 21324976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of glucose and inflammatory cytokines on TGF-beta1 and CTGF mRNA expressions in human peritoneal mesothelial cells.
    Sakamoto N; Sugimura K; Kawashima H; Tsuchida K; Takemoto Y; Naganuma T; Tatsumi S; Nakatani T
    Int J Mol Med; 2005 Jun; 15(6):907-11. PubMed ID: 15870892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
    Lin CY; Chen WP; Yang LY; Chen A; Huang TP
    Am J Nephrol; 1998; 18(6):513-9. PubMed ID: 9845827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tanshinone IIA attenuates peritoneal fibrosis through inhibition of fibrogenic growth factors expression in peritoneum in a peritoneal dialysis rat model.
    Chunming J; Miao Z; Cheng S; Nana T; Wei Z; Dongwei C; Yuan F
    Ren Fail; 2011; 33(3):355-62. PubMed ID: 21401363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connective tissue growth factor knockdown attenuated matrix protein production and vascular endothelial growth factor expression induced by transforming growth factor-beta1 in cultured human peritoneal mesothelial cells.
    Xiao L; Sun L; Liu FY; Peng YM; Duan SB
    Ther Apher Dial; 2010 Feb; 14(1):27-34. PubMed ID: 20438517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
    Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
    Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
    Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
    Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage.
    Loureiro J; Aguilera A; Selgas R; Sandoval P; Albar-Vizcaíno P; Pérez-Lozano ML; Ruiz-Carpio V; Majano PL; Lamas S; Rodríguez-Pascual F; Borras-Cuesta F; Dotor J; López-Cabrera M
    J Am Soc Nephrol; 2011 Sep; 22(9):1682-95. PubMed ID: 21742730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connective tissue growth factor is a positive regulator of epithelial-mesenchymal transition and promotes the adhesion with gastric cancer cells in human peritoneal mesothelial cells.
    Jiang CG; Lv L; Liu FR; Wang ZN; Na D; Li F; Li JB; Sun Z; Xu HM
    Cytokine; 2013 Jan; 61(1):173-80. PubMed ID: 23073116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of transforming growth factor-beta on the synthesis of connective tissue growth factor and vascular endothelial growth factor by peritoneal mesothelial cell.
    Szeto CC; Lai KB; Chow KM; Szeto CY; Wong TY; Li PK
    Nephron Exp Nephrol; 2005; 99(4):e95-e104. PubMed ID: 15703462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
    Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
    Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High glucose solution and spent dialysate stimulate the synthesis of transforming growth factor-beta1 of human peritoneal mesothelial cells: effect of cytokine costimulation.
    Kang DH; Hong YS; Lim HJ; Choi JH; Han DS; Yoon KI
    Perit Dial Int; 1999; 19(3):221-30. PubMed ID: 10433158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between peritoneal transport characteristics and messenger RNA expression of aquaporin in the peritoneal dialysis effluent of CAPD patients.
    Szeto CC; Lai KB; Chow KM; Szeto CY; Li PK
    J Nephrol; 2005; 18(2):197-203. PubMed ID: 15931648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factors in continuous ambulatory peritoneal dialysis effluent. Their relation with peritoneal transport of small solutes.
    Lai KN; Lai KB; Szeto CC; Lam CW; Leung JC
    Am J Nephrol; 1999; 19(3):416-22. PubMed ID: 10393381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overnight mesothelial cell exfoliation: a magic tool for predicting future ultrafiltration failure in patients on continuous ambulatory peritoneal dialysis.
    Kanjanabuch T; Siribamrungwong M; Khunprakant R; Kanjanabuch S; Jeungsmarn P; Achavanuntakul B; Pongpirul K; Park MS; Tungsanga K; Eiam-Ong S
    Perit Dial Int; 2008 Jun; 28 Suppl 3():S107-13. PubMed ID: 18552238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.